675 related articles for article (PubMed ID: 9538386)
1. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
2. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
3. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.
Li J; Shen H; Hou T; Li M; He S; Zhang H
Spine (Phila Pa 1976); 2009 Apr; 34(8):E305-8. PubMed ID: 19365240
[TBL] [Abstract][Full Text] [Related]
4. [Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms].
Szczepanik AB; Wisławski S; Windyga J; Huszcza S; Bilski R; Meissner AJ
Pol Merkur Lekarski; 2009 Nov; 27(161):375-80. PubMed ID: 19999800
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
Mansouritorghabeh H; Lak M; van Heerde WL
Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
8. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
9. [Macrohaematuria post-partum: an unusual case of acquired haemophilia after pregnancy].
Prencipe MA; D'Errico M; Di Giorgio G; Gatta G; Gesuete A; Nobile M; Stallone C
G Ital Nefrol; 2002; 19(2):204-8. PubMed ID: 12195420
[TBL] [Abstract][Full Text] [Related]
10. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
11. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
12. [Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus].
Pirner K; Rösler W; Kalden JR; Manger B
Z Rheumatol; 1990; 49(6):378-81. PubMed ID: 2128157
[TBL] [Abstract][Full Text] [Related]
13. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
[TBL] [Abstract][Full Text] [Related]
14. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
15. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. [Acquired haemophilia A].
Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ
Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188
[TBL] [Abstract][Full Text] [Related]
19. The management of factor VIII inhibitors in non-hemophilic patients.
Green D
Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
Meili EO; Dazzi H; von Felten A
Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
